Protein Target & Pipeline Database: 1-Year Subscription

Publisher: La Merie Publishing
Format: Online Database
Product Code: LMDB0007
Release Date: July of 2013

1,200.00 €
Free of 19 % VAT (except in Germany and also in the European Union without valid intl. VAT no),
Delivery costs do not apply or are included.
License:
You can also order this product via email or fax , please download the Order Form
Need more information?
Ask a question about this product

Protein Target & Pipeline Database: 1-Year Subscription

Product description

Subscription to La Merie Publishing’s proprietary Protein Database provides online access to information about more than 1900 project entries for therapeutic proteins on the market and in research & development. Pre-established and free search functions allow to identify proteins according to their

  • Target (e.g. Factor VIII, G-CSF, FSH)
  • Pipelines (selected by target, therapeutic area, company)
  • Sales (for marketed proteins)
  • R&D Phase (clinical phases, market, preclinical)
  • Territory (countrywise)
  • Therapeutic Area (e.g. infectious, oncology, gastrointestinal)
  • Drug Code/Name (for individual molecules)

Each project is specified for its Target, Therapeutic Area and R&D Phase. Use of the R&D database of therapeutic proteins is intuitive. Data sets of interest can be printed and exported as reports in Excel or Word format. Projects are being updated continuously. The R&D history of each project with online references of information sources can be viewed and printed. Sales figures of major therapeutic proteins on the market are provided. An advanced search function allows to combine search parameters. A scroll down menu for predefined targets conveniently selects projects of interest. By clicking on column heads of the project list, projects can be arranged in ascending or descending alphabetical or numerical order, e.g. for phase or company name.

Special Focus of the Database:

  • Biosimilar and Biosuperior Proteins

See our sample screenshots of the database: Download sample screenshots

Prerequisite: Internet access

Purchase of the subscription provides a 1-year online access to the data of the Protein Target & Pipeline Database. Credentials to access the database will be sent by e-mail within 24 hours after purchase.

Benefits from the Protein Target & Pipeline Database:

  • Intuitive use
  • Designed for structured searches
  • Focused on targets, therapeutic areas and R&D phases
  • Ideal for competitor analysis (companies, targets, technologies, R&D phase)
  • Cost-effective and rapid solution for benchmarking
  • Identification of licensing candidates

Project listing in a tabular format:

  • Drug Codes
  • Target
  • Class of Compound
  • Company
  • Territory
  • Therapeutic Area
  • Indication
  • R&D Phase

Therapeutic Areas:

  • Cardiovascular & blood
  • Dermatology
  • Gastrointestinal
  • Genitourinary, renal & gynecology
  • Infectious & toxicology
  • Metabolism & endocrine
  • Neurology & psychiatry
  • Oncology
  • Ophthalmology & otorhinolaryngology
  • Orthopedics, dental, anesthesia & surgery
  • Pulmonary & respiratory
  • Rheumatoid & autoimmune

Predefined Targets of the Scroll Down Menu - examples:

•          Coagulation Factors
•          Erythropoietin (EPO) & Erythropoiesis Stimulating Agents (ESA)
•          G-CSF & GM-CSF
•          Thrombopoietin (TPO) & Thrombopoiesis Stimulating Agents
•          Interferon
•          Insulin
•          Human Growth Hormone (hGH)
•          FSH, LH & hCG (Assisted Reproduction Technology: ART)
•          Thrombolytics & Fibrinolytics
•          Enzyme Replacement Therapies (ERT)
•          Growth Factors (e.g. FGF, PDGF, EGF, VEGF, TGF, NGF)

 


The above shown price refers to a Single User License. Please contact us for prices of departmental, site or global product licenses.

This Report is NOT a downloadable item but will be delivered via email within 24 h (working days only).

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top